Ultragenyx Pharmaceutical Inc.
Develops and commercializes novel therapies for rare and ultra-rare genetic diseases.
RARE | US
Overview
Corporate Details
- ISIN(s):
- US90400D1081
- LEI:
- Country:
- United States of America
- Address:
- 60 LEVERONI COURT, 94949 NOVATO
- Website:
- https://www.ultragenyx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company dedicated to developing and commercializing novel therapies for serious rare and ultra-rare genetic diseases. The company focuses on bringing first-ever approved treatments to patients with high unmet medical needs. Ultragenyx maintains one of the most robust and diverse clinical pipelines in the rare disease field, utilizing a range of therapeutic modalities to create transformative medicines. Its approach integrates deep scientific expertise in drug development and commercialization with a strong commitment to collaborating with and supporting rare disease communities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ultragenyx Pharmaceutical Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ultragenyx Pharmaceutical Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ultragenyx Pharmaceutical Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
